A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...
Newswise — Investigators at Vanderbilt Health are enrolling participants in a Phase 3 clinical trial testing an investigational vaccine against Clostridioides difficile, or C. diff, a contagious ...
EAST SYRACUSE, N.Y. (WSYR-TV) — The Upstate Institute for Global Health is looking for over 1,000 Central New Yorkers to participate in its largest clinical trial, testing a possible vaccine to ...
Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
The Johns Hopkins CIR is looking for healthy volunteers to participate in an outpatient C. difficile vaccine study. The purpose of this study is to test an investigational vaccine to see if it can ...
Clostridium difficile infections affect hundreds of thousands of Americans each year, but new research from the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, may help develop a ...
Add Yahoo as a preferred source to see more of our stories on Google. UVM is one of more than 170 sites around the world looking for volunteers 65 and older to take part in a three and a half year ...
A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results